INSULIN SECRETION AND SENSITIVITY AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION ESTIMATED BY CONTINUOUS INFUSION OF GLUCOSE WITH MODEL ASSESSMENT
| Autor: | Jan Ringers, J.W. de Fijter, Herman H.P.J. Lemkes, J.W. van der Pijl, M. Frölich, Y. F. C. Smets |
|---|---|
| Rok vydání: | 2000 |
| Předmět: |
Adult
Male medicine.medical_specialty medicine.medical_treatment Pancreas transplantation Carbohydrate metabolism Insulin resistance Internal medicine Insulin Secretion medicine Humans Insulin Prospective Studies Infusions Intravenous Transplantation Kidney business.industry Metabolism Middle Aged medicine.disease Kidney Transplantation Solutions Glucose Endocrinology medicine.anatomical_structure Female Pancreas Transplantation Insulin Resistance business Pancreas |
| Zdroj: | Transplantation. 69:1322-1327 |
| ISSN: | 0041-1337 |
| DOI: | 10.1097/00007890-200004150-00018 |
| Popis: | BACKGROUND Monitoring of insulin secretion and sensitivity after pancreas transplantation remains a practical problem. METHODS We introduced the simple structural model, continuous infusion of glucose with model assessment (CIGMA), to obtain insulin secretion and insulin sensitivity estimations after 35 successful simultaneous pancreas-kidney transplantations. Eighteen non-diabetic kidney transplant recipients were used as control group. RESULTS The baseline characteristics were equal between the two groups except for higher fasting insulin levels in the pancreas transplant group. After the 1-hr CIGMA glucose load, the pancreas transplant group reached a mean +/- SD blood glucose of 8.2+/-1.7 mmol/L compared with 7.3+/-1.0 mmol/L in the control group (P = 0.05). Concurrent stimulated insulin and C-peptide levels were 48+/-28 mU/L and 2.3+/-0.9 nmol/L in the pancreas transplant group compared with 36+/-21 mU/L and 2.9+/-1.1 nmol/L in the control group (P = 0.1 and P = 0.03, respectively). Both the CIGMA estimation for secretion as well as the CIGMA estimation for sensitivity were lower in pancreas transplant group (P = 0.003 and P = 0.01, respectively). Mean +/- SE coefficients of variation for the model estimations were 15+/-4% for secretion and 17+/-6% for sensitivity. CONCLUSIONS We conclude that CIGMA can be used clinically to evaluate carbohydrate metabolism in pancreas-kidney transplant recipients. These patients have a reduction in insulin secretory capacity and evidence of more insulin resistance than non-diabetic kidney transplant recipients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|